The phospholipase A2 inhibitor, quinacrine, reduces infarct size in rats after transient middle cerebral artery occlusion
- 1 March 1997
- journal article
- Published by Elsevier in Brain Research
- Vol. 752 (1-2), 203-208
- https://doi.org/10.1016/s0006-8993(96)01450-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Temporal Correlation Analysis of Penumbral Dynamics in Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 1996
- Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats.Stroke, 1994
- Chronological atrophy after transient middle cerebral artery occlusion in ratsBrain Research, 1993
- Deoxycoformycin and oxypurinol: protection against focal ischemic brain injury in the ratBrain Research, 1992
- Reduction in infarct size by the phospholipase inhibitor quinacrine in dogs with coronary artery occlusionAmerican Heart Journal, 1990
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989
- Mechanism of Arachidonic Acid Liberation During Ischemia in Gerbil Cerebral CortexJournal of Neurochemistry, 1987
- Quinacrine-positive neurones in some regions of the guinea-pig brainBrain Research Bulletin, 1984
- Pharmacokinetic studies on quinacrine following intrauterine administration to cynomolgus monkeys**Supported by the International Fertility Research Program Subcontracts 601 and 603.Fertility and Sterility, 1982
- Thresholds in cerebral ischemia - the ischemic penumbra.Stroke, 1981